BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: LeRoith D, Holly JMP, Forbes BE. Insulin-like growth factors: Ligands, binding proteins, and receptors. Mol Metab 2021;52:101245. [PMID: 33962049 DOI: 10.1016/j.molmet.2021.101245] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Selicharová I, Mitrová K, Fabre B, Miriyala VM, Lepšík M, Jiráček J, Hernández MSG. Targeting the insulin receptor with hormone and peptide dimers. J Pept Sci 2023;29:e3461. [PMID: 36336650 DOI: 10.1002/psc.3461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang H, Yu R, Wang M, Wang S, Ouyang X, Yan Z, Chen S, Wang W, Wu F, Fan C. Insulin-like growth factor binding protein 4 loaded electrospun membrane ameliorating tendon injury by promoting retention of IGF-1. J Control Release 2023;356:162-74. [PMID: 36868516 DOI: 10.1016/j.jconrel.2023.02.039] [Reference Citation Analysis]
3 Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, Gunter MJ, Holmes MV, Martin RM, Tsilidis KK, Albanes D, Barricarte A, Bueno-de-Mesquita HB, Cohn BA, Deschasaux-Tanguy M, Dimou NL, Ferrucci L, Flicker L, Freedman ND, Giles GG, Giovannucci EL, Haiman CA, Hankey GJ, Holly JMP, Huang J, Huang WY, Hurwitz LM, Kaaks R, Kubo T, Le Marchand L, MacInnis RJ, Männistö S, Metter EJ, Mikami K, Mucci LA, Olsen AW, Ozasa K, Palli D, Penney KL, Platz EA, Pollak MN, Roobol MJ, Schaefer CA, Schenk JM, Stattin P, Tamakoshi A, Thysell E, Tsai CJ, Touvier M, Van Den Eeden SK, Weiderpass E, Weinstein SJ, Wilkens LR, Yeap BB, Allen NE, Key TJ, Travis RC; PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol 2023;52:71-86. [PMID: 35726641 DOI: 10.1093/ije/dyac124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Fertan E, Gendron WH, Wong AA, Hanson GM, Brown RE, Weaver ICG. Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1-42 in Alzheimer's disease. Sci Rep 2023;13:2043. [PMID: 36739453 DOI: 10.1038/s41598-023-29248-x] [Reference Citation Analysis]
5 García-Mato Á, Cervantes B, Rodríguez-de la Rosa L, Varela-Nieto I. IGF-1 Controls Metabolic Homeostasis and Survival in HEI-OC1 Auditory Cells through AKT and mTOR Signaling. Antioxidants (Basel) 2023;12. [PMID: 36829792 DOI: 10.3390/antiox12020233] [Reference Citation Analysis]
6 Belfiore A, Rapicavoli RV, Le Moli R, Lappano R, Morrione A, De Francesco EM, Vella V. IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines 2023;11. [PMID: 36672737 DOI: 10.3390/biomedicines11010229] [Reference Citation Analysis]
7 Rosetti B, Marchesan S. Peptide Inhibitors of Insulin Fibrillation: Current and Future Challenges. Int J Mol Sci 2023;24. [PMID: 36674821 DOI: 10.3390/ijms24021306] [Reference Citation Analysis]
8 Gorai B, Vashisth H. Structural models of viral insulin-like peptides and their analogs. Proteins 2023;91:62-73. [PMID: 35962629 DOI: 10.1002/prot.26410] [Reference Citation Analysis]
9 Du H, Zhou Y, Du X, Zhang P, Cao Z, Sun Y. Insulin-like growth factor binding protein 5b of Trachinotus ovatus and its heparin-binding motif play a critical role in host antibacterial immune responses via NF-κB pathway. Front Immunol 2023;14:1126843. [PMID: 36865533 DOI: 10.3389/fimmu.2023.1126843] [Reference Citation Analysis]
10 Lin J, Asai S, Selicharová I, Mitrová K, Kaminský J, Young E, Jiráček J. Recombinant Insulin-Like Growth Factor 1 Dimers: Receptor Binding Affinities and Activation Abilities. Int J Pept Res Ther 2023;29:33. [PMID: 36891560 DOI: 10.1007/s10989-023-10499-1] [Reference Citation Analysis]
11 Afzal M, Kazmi I, Kaur R, Hosawi SBI, Kaleem M, Alzarea SI, Ahmad MM. Introduction to molecular pharmacology: basic concepts. How Synthetic Drugs Work 2023. [DOI: 10.1016/b978-0-323-99855-0.00001-4] [Reference Citation Analysis]
12 Jiráček J, Selicharová I, Žáková L. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2. Vitamins and Hormones 2023. [DOI: 10.1016/bs.vh.2023.01.010] [Reference Citation Analysis]
13 Alonso-Gómez A, Madera D, Alonso-Gómez ÁL, Valenciano AI, Delgado MJ. Daily Rhythms in the IGF-1 System in the Liver of Goldfish and Their Synchronization to Light/Dark Cycle and Feeding Time. Animals (Basel) 2022;12. [PMID: 36496892 DOI: 10.3390/ani12233371] [Reference Citation Analysis]
14 Guo S, Zheng J, Li G. Effects of growth hormone on lipid metabolism and sexual development in pubertal obese male rats. Open Life Sciences 2022;17:1531-1540. [DOI: 10.1515/biol-2022-0515] [Reference Citation Analysis]
15 Kubo H, Sawada S, Satoh M, Asai Y, Kodama S, Sato T, Tomiyama S, Seike J, Takahashi K, Kaneko K, Imai J, Katagiri H. Insulin-like growth factor-1 levels are associated with high comorbidity of metabolic disorders in obese subjects; a Japanese single-center, retrospective-study. Sci Rep 2022;12:20130. [PMID: 36418379 DOI: 10.1038/s41598-022-23521-1] [Reference Citation Analysis]
16 Masbuchin AN, Widodo, Rohman MS, Liu PY. The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system? Front Cardiovasc Med 2022;9:986570. [PMID: 36237897 DOI: 10.3389/fcvm.2022.986570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hossen MN, Wang L, Dwivedi SKD, Zhang Y, Rao G, Elechalwar CK, Sheth V, Dey A, Asfa S, Gulla SK, Xu C, Fung K, Robertson JD, Bieniasz M, Wilhelm S, Bhattacharya R, Mukherjee P. Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth. Advanced Science. [DOI: 10.1002/advs.202200491] [Reference Citation Analysis]
18 Sandovici I, Fernandez-twinn DS, Campbell N, Cooper WN, Sekita Y, Zvetkova I, Ferland-mccollough D, Prosser HM, Oyama LM, Cimadomo D, de Queiroz KB, Cheuk CS, Smith NM, Kay RG, Hoelle K, Smith NH, Geyer SH, Reissig LF, Weninger WJ, Siddle K, Willis AE, Bushell M, Ozanne SE, Constância M. The imprinted Mir483 is a growth suppressor and metabolic regulator functioning through IGF1.. [DOI: 10.1101/2022.09.09.507324] [Reference Citation Analysis]
19 Jaipuria G, Shet D, Malik S, Swain M, Atreya HS, Galea CA, Slomiany MG, Rosenzweig SA, Forbes BE, Norton RS, Mondal S. IGF-dependent dynamic modulation of a protease cleavage site in the intrinsically disordered linker domain of human IGFBP2. Proteins 2022;90:1732-43. [PMID: 35443068 DOI: 10.1002/prot.26350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kubo H, Sawada S, Satoh M, Asai Y, Kodama S, Takahashi K, Kaneko K, Imai J, Katagiri H, Sato T, Tomiyama S, Seike J. Low Insulin-Like Growth Factor-1 Levels Are Associated with High Comorbidity of Metabolic Diseases in Subjects with Severe Obesity.. [DOI: 10.21203/rs.3.rs-1939345/v1] [Reference Citation Analysis]
21 Gligorijević N, Dobrijević Z, Šunderić M, Robajac D, Četić D, Penezić A, Miljuš G, Nedić O. The Insulin-like Growth Factor System and Colorectal Cancer. Life (Basel) 2022;12:1274. [PMID: 36013453 DOI: 10.3390/life12081274] [Reference Citation Analysis]
22 Fang F, Goldstein JL, Shi X, Liang G, Brown MS. Unexpected role for IGF-1 in starvation: Maintenance of blood glucose. Proc Natl Acad Sci U S A 2022;119:e2208855119. [PMID: 35914126 DOI: 10.1073/pnas.2208855119] [Reference Citation Analysis]
23 Liu H, Guo Q, Zhang L, Tian X, Ma X, Zhang J, Li X. The insulin-like growth factor 1 stimulates ovarian steroidogenesis and oocyte maturation in spotted steed Hemibarbus maculatus. J Steroid Biochem Mol Biol 2022;:106159. [PMID: 35931326 DOI: 10.1016/j.jsbmb.2022.106159] [Reference Citation Analysis]
24 Vella V, De Francesco EM, Bonavita E, Lappano R, Belfiore A. IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis. Trends Endocrinol Metab 2022;33:569-86. [PMID: 35691786 DOI: 10.1016/j.tem.2022.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zeng J, Ji Y, Luan F, Hu J, Rui Y, Liu Y, Rao Z, Liu R, Zeng N. Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1Rβ/PI3K/Akt signaling pathway. Journal of Ethnopharmacology 2022;288:115005. [DOI: 10.1016/j.jep.2022.115005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Yang Q, Li X, Shi R, Cheng P, Wang N, Chen S. The female-biased expression, transcriptional regulation and knock-down effect of insulin-like growth factor binding protein 7 in Chinese tongue sole, Cynoglossus semilaevis. Aquaculture 2022;551:737956. [DOI: 10.1016/j.aquaculture.2022.737956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Di Patria L, Annibalini G, Morrone A, Ferri L, Saltarelli R, Galluzzi L, Diotallevi A, Bocconcelli M, Donati MA, Barone R, Guerrini R, Jaeken J, Stocchi V, Barbieri E. Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation. Cell Mol Life Sci 2022;79:150. [PMID: 35211808 DOI: 10.1007/s00018-022-04180-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Strojny W, Czogała W, Tomasik P, Bik-Multanowski M, Wójcik M, Miklusiak K, Miklusiak K, Hałubiec P, Skoczeń S. Concentrations of Insulin-like Growth Factors and Insulin-like Growth Factor-Binding Proteins and Respective Gene Expressions in Children before and after Hematopoietic Stem Cell Transplantation. Nutrients 2021;13:4333. [PMID: 34959885 DOI: 10.3390/nu13124333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Brierley GV, Semple RK. Insulin at 100 years - is rebalancing its action key to fighting obesity-related disease? Dis Model Mech 2021;14:dmm049340. [PMID: 34841432 DOI: 10.1242/dmm.049340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 García-Mato Á, Cervantes B, Murillo-Cuesta S, Rodríguez-de la Rosa L, Varela-Nieto I. Insulin-like Growth Factor 1 Signaling in Mammalian Hearing. Genes (Basel) 2021;12:1553. [PMID: 34680948 DOI: 10.3390/genes12101553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Duan X, Wang W, Pan Q, Guo L. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development. Front Oncol 2021;11:730038. [PMID: 34485159 DOI: 10.3389/fonc.2021.730038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kahn CR. "100 Years of progress in understanding insulin, its mechanism of action, and its roles in disease and diabetes therapy". Mol Metab 2021;52:101318. [PMID: 34478731 DOI: 10.1016/j.molmet.2021.101318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Mancarella C, Morrione A, Scotlandi K. Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options. Cells 2021;10:2075. [PMID: 34440844 DOI: 10.3390/cells10082075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]